rs11710163

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002880.4(RAF1):​c.-27+9024T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0646 in 125,476 control chromosomes in the GnomAD database, including 348 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.065 ( 348 hom., cov: 26)

Consequence

RAF1
NM_002880.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.468

Publications

18 publications found
Variant links:
Genes affected
RAF1 (HGNC:9829): (Raf-1 proto-oncogene, serine/threonine kinase) This gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. [provided by RefSeq, Jul 2008]
RAF1 Gene-Disease associations (from GenCC):
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Noonan syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, G2P
  • dilated cardiomyopathy 1NN
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • LEOPARD syndrome 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0923 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAF1NM_002880.4 linkc.-27+9024T>C intron_variant Intron 1 of 16 ENST00000251849.9 NP_002871.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAF1ENST00000251849.9 linkc.-27+9024T>C intron_variant Intron 1 of 16 1 NM_002880.4 ENSP00000251849.4

Frequencies

GnomAD3 genomes
AF:
0.0647
AC:
8107
AN:
125362
Hom.:
348
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.0166
Gnomad AMI
AF:
0.00948
Gnomad AMR
AF:
0.0709
Gnomad ASJ
AF:
0.107
Gnomad EAS
AF:
0.00157
Gnomad SAS
AF:
0.0304
Gnomad FIN
AF:
0.0786
Gnomad MID
AF:
0.0819
Gnomad NFE
AF:
0.0944
Gnomad OTH
AF:
0.0691
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0646
AC:
8104
AN:
125476
Hom.:
348
Cov.:
26
AF XY:
0.0627
AC XY:
3739
AN XY:
59614
show subpopulations
African (AFR)
AF:
0.0165
AC:
591
AN:
35756
American (AMR)
AF:
0.0709
AC:
783
AN:
11044
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
323
AN:
3022
East Asian (EAS)
AF:
0.00157
AC:
5
AN:
3192
South Asian (SAS)
AF:
0.0305
AC:
97
AN:
3182
European-Finnish (FIN)
AF:
0.0786
AC:
579
AN:
7366
Middle Eastern (MID)
AF:
0.0818
AC:
18
AN:
220
European-Non Finnish (NFE)
AF:
0.0944
AC:
5584
AN:
59150
Other (OTH)
AF:
0.0682
AC:
116
AN:
1700
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.590
Heterozygous variant carriers
0
239
477
716
954
1193
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0699
Hom.:
710
Bravo
AF:
0.0508

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
5.4
DANN
Benign
0.75
PhyloP100
0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11710163; hg19: chr3-12696288; API